{"id":62655,"date":"2022-04-13T10:49:28","date_gmt":"2022-04-13T08:49:28","guid":{"rendered":"https:\/\/blog.cofb.cat\/?p=62655"},"modified":"2023-09-21T09:18:03","modified_gmt":"2023-09-21T09:18:03","slug":"nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/","title":{"rendered":"Nova formaci\u00f3 sobre les indicacions i els tractaments de les hipogluc\u00e8mies greus al COFB"},"content":{"rendered":"\n<p>El <strong>passat 7 d&#8217;abril<\/strong> va tenir lloc al <strong>Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB)<\/strong> la <strong>formaci\u00f3<\/strong> <strong>&#8220;Hipogluc\u00e8mies greus, qu\u00e8 hi podem fer? Indicacions i tractaments&#8221;<\/strong>. Patrocinada per <a href=\"https:\/\/www.lilly.com\/\" target=\"_blank\" rel=\"noreferrer noopener\">Lilly<\/a> i organitzada conjuntament amb la <a href=\"http:\/\/www.scfarmclin.org\/\" target=\"_blank\" rel=\"noreferrer noopener\">Societat Catalana de Farm\u00e0cia Cl\u00ednica<\/a>, tenia per <strong>objectius<\/strong> que els assistents es posessin al dia pel que fa a les <strong>guies<\/strong> i les <strong>recomanacions<\/strong> per tractar les <strong>hipogluc\u00e8mies<\/strong> i les <strong>hipogluc\u00e8mies greus<\/strong>, ampliessin <strong>coneixements<\/strong> sobre els <strong>tractaments disponibles<\/strong> i adquirissin <strong>habilitats d\u2019actuaci\u00f3 farmac\u00e8utica<\/strong> en el <strong>tractament del pacient<\/strong>. <\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/04\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513.jpg\" alt=\"El passat 7 d'abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 &quot;Hipogluc\u00e8mies greus, qu\u00e8 hi podem fer? Indicacions i tractaments&quot;. \" class=\"wp-image-62908\" title=\"El passat 7 d'abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 &quot;Hipogluc\u00e8mies greus, qu\u00e8 hi podem fer? Indicacions i tractaments&quot;. \"\/><figcaption class=\"wp-element-caption\"> El passat 7 d&#8217;abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 &#8220;Hipogluc\u00e8mies greus, qu\u00e8 hi podem fer? Indicacions i tractaments&#8221;. <\/figcaption><\/figure>\n\n\n\n<p>La <strong>formaci\u00f3<\/strong> s&#8217;adre\u00e7ava a <strong>farmac\u00e8utics hospitalaris<\/strong>, d&#8217;<strong>Atenci\u00f3 Prim\u00e0ria<\/strong> i <strong>comunitaris<\/strong>. Les ponents van ser la <strong>Dra. Marga Gim\u00e9nez<\/strong>, cap de la Unitat de Diabetis, del Departament d&#8217;Endocrinologia de l&#8217;Hospital Cl\u00ednic i <strong>Cristina Morales<\/strong>, farmac\u00e8utica d&#8217;Atenci\u00f3 Prim\u00e0ria de la Unitat de Farm\u00e0cia del SAP Vall\u00e8s Oriental.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Aspectes cl\u00ednics i conseq\u00fc\u00e8ncies<\/strong> <strong>de les hipogluc\u00e8mies<\/strong><\/h2>\n\n\n\n<p>Tal com va exposar la Dra. Marga Gim\u00e9nez, &#8220;en <strong>diabetis<\/strong>, en els \u00faltims anys, ha canviat la definici\u00f3 d&#8217;<strong>hipogluc\u00e8mia<\/strong>. De fet, entenem com a <strong>hipogluc\u00e8mia <\/strong>qualsevol episodi en el qual el pacient presenta una <strong>gluc\u00e8mia inferior a 70 mg\/dL<\/strong>. En la darrera \u00e8poca, els <strong>episodis d&#8217;hipogluc\u00e8mia<\/strong> s&#8217;han dividit en <strong>dos nivells<\/strong>. Entenem com a <strong>nivell 1 <\/strong>els valors d&#8217;hipogluc\u00e8mia entre <strong>70 i 54 mg\/dL<\/strong> i com a <strong>nivell 2<\/strong> es consideren tots els episodis que tenen associat un valor de glucosa <strong>per sota de 54<\/strong>. En aquest segon nivell, \u00e9s quan el risc de <strong>neuroglucop\u00e8nia<\/strong> i <strong>esdeveniments aguts<\/strong> i el <strong>risc d&#8217;hipogluc\u00e8mia greu<\/strong> s&#8217;incrementa&#8221;. <\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/04\/1649334856483-1024x576.jpg\" alt=\"La Dra. Marga Gim\u00e9nez, cap de la Unitat de Diabetis, del Departament d'Endocrinologia de l'Hospital Cl\u00ednic.\" class=\"wp-image-62914\" title=\"La Dra. Marga Gim\u00e9nez, cap de la Unitat de Diabetis, del Departament d'Endocrinologia de l'Hospital Cl\u00ednic.\"\/><figcaption class=\"wp-element-caption\">La Dra. Marga Gim\u00e9nez, cap de la Unitat de Diabetis, del Departament d&#8217;Endocrinologia de l&#8217;Hospital Cl\u00ednic.<\/figcaption><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Simptomatologia<\/strong><\/h3>\n\n\n\n<p>Pel que fa a la <strong>simptomatologia<\/strong> associada als <strong>episodis d&#8217;hipogluc\u00e8mia<\/strong>, la <strong>Dra. Gim\u00e9nez<\/strong> va diferenciar, d&#8217;una banda, &#8220;els s\u00edmptomes m\u00e9s <strong>adren\u00e8rgics<\/strong> i que solen presentar-se a l&#8217;<strong>inici de la malaltia<\/strong>, durant els primers anys. Acostumen a ser <strong>simptomatologies vinculades a l&#8217;estr\u00e8s<\/strong>, que fan que la persona se senti malament i tingui <strong>ganes de menjar<\/strong> (exemple: suor, gana, trobar-se malament, palpitacions, sensaci\u00f3 que d&#8217;haver de buscar alguna cosa per menjar i resoldre aquella situaci\u00f3). Aix\u00f2 \u00e9s el que acaba constituint el que coneixem com la <strong>tr\u00edada<\/strong> de la <strong>detecci\u00f3<\/strong> i el <strong>tractament<\/strong> de la <strong>hipogluc\u00e8mia<\/strong>. En altres paraules: determinar el valor de glucosa, tenir s\u00edmptomes compatibles, menjar i que desapareguin els s\u00edmptomes&#8221;. <\/p>\n\n\n\n<p>D&#8217;altra banda, la doctora va afegir que &#8220;quan aix\u00f2 succeeix durant moltes vegades, al llarg de molts anys, o quan hi ha <strong>determinats f\u00e0rmacs<\/strong> o <strong>situacions concomitants<\/strong>, amb el temps es van perdent aquests <strong>s\u00edmptomes adren\u00e8rgics<\/strong> i apareixen uns <strong>altres s\u00edmptomes<\/strong> que s\u00f3n <strong>neuroglucop\u00e8nics<\/strong>, que ja no s\u00f3n tan f\u00e0cils de detectar (la persona ja no t\u00e9 la necessitat de menjar alguna cosa dol\u00e7a) i potser l&#8217;<strong>\u00fanica simptomatologia <\/strong>\u00e9s que ja no<strong> \u00e9s capa\u00e7 de concentrar-se en la feina<\/strong> que est\u00e0 fent o que fa alguna <strong>cosa rutin\u00e0ria<\/strong> moltes vegades seguides&#8221;. <\/p>\n\n\n\n<figure class=\"wp-block-image aligncenter size-full\"><img decoding=\"async\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/04\/COFB_Hipoglucemies-greus_070422_3.jpg\" alt=\"Cristina Morales, farmac\u00e8utica d'Atenci\u00f3 Prim\u00e0ria de la Unitat de Farm\u00e0cia del SAP Vall\u00e8s Oriental i la Dra. Marga Gim\u00e9nez, cap de la Unitat de Diabetis, del Departament d'Endocrinologia de l'Hospital Cl\u00ednic.\" class=\"wp-image-63011\" title=\"Cristina Morales, farmac\u00e8utica d'Atenci\u00f3 Prim\u00e0ria de la Unitat de Farm\u00e0cia del SAP Vall\u00e8s Oriental i la Dra. Marga Gim\u00e9nez, cap de la Unitat de Diabetis, del Departament d'Endocrinologia de l'Hospital Cl\u00ednic.\"\/><figcaption class=\"wp-element-caption\">Cristina Morales, farmac\u00e8utica d&#8217;Atenci\u00f3 Prim\u00e0ria de la Unitat de Farm\u00e0cia del SAP Vall\u00e8s Oriental i la Dra. Marga Gim\u00e9nez, cap de la Unitat de Diabetis, del Departament d&#8217;Endocrinologia de l&#8217;Hospital Cl\u00ednic.<\/figcaption><\/figure>\n\n\n\n<p>Sigui com sigui, segons va exposar la doctora, &#8220;independentment del <strong>valor de glucosa<\/strong> que tinguis o independentment dels <strong>s\u00edmptomes que tinguis<\/strong>, es considerar\u00e0 greu qualsevol <strong>hipogluc\u00e8mia<\/strong> quan <strong>vagi associada<\/strong> a un <strong>estat de neuroglucop\u00e8nia<\/strong> suficient com perqu\u00e8 el pacient no sigui capa\u00e7 de <strong>resoldre aquella situaci\u00f3<\/strong>&#8220;. <\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>El professional farmac\u00e8utic i l&#8217;educaci\u00f3 diabetol\u00f2gica<\/strong><\/h2>\n\n\n\n<p>Per la seva banda, <strong>Cristina Morales<\/strong>, farmac\u00e8utica d&#8217;atenci\u00f3 prim\u00e0ria de la <strong>Unitat de Farm\u00e0cia SAP Vall\u00e8s Oriental<\/strong>, va comen\u00e7ar la seva <strong>intervenci\u00f3<\/strong> referint-se a l<strong>&#8216;objectiu del tractament <\/strong>de la <strong>hipogluc\u00e8mia greu<\/strong>, que consisteix en <strong>normalitzar la concentraci\u00f3 de glucosa plasm\u00e0tica<\/strong>. Tot seguit, va fer refer\u00e8ncia als tipus de <strong>glucag\u00f3<\/strong>, als<strong> mecanismes d&#8217;acci\u00f3 <\/strong>d&#8217;aquest i a la seva <strong>indicaci\u00f3<\/strong> i <strong>posologia<\/strong>.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/04\/COFB_Hipoglucemies-greus_070422_2-1024x585.jpg\" alt=\"Cristina Morales, farmac\u00e8utica d'Atenci\u00f3 Prim\u00e0ria de la Unitat de Farm\u00e0cia SAP Vall\u00e8s Oriental. \" class=\"wp-image-62988\" title=\"Cristina Morales, farmac\u00e8utica d'atenci\u00f3 prim\u00e0ria de la Unitat de Farm\u00e0cia SAP Vall\u00e8s Oriental.\"\/><figcaption class=\"wp-element-caption\">Cristina Morales, farmac\u00e8utica d&#8217;Atenci\u00f3 Prim\u00e0ria de la Unitat de Farm\u00e0cia SAP Vall\u00e8s Oriental.<\/figcaption><\/figure>\n\n\n\n<p>Aix\u00ed com a les <strong>situacions especials<\/strong> i les <strong>contraindicacions<\/strong> (<strong>hipersensibilitat principi actiu<\/strong> i\/o <strong>excipients<\/strong>, <strong>feocromocitoma<\/strong> i i<strong>nsulinoma<\/strong>). Tamb\u00e9 va recordar que el <strong>glucag\u00f3<\/strong> no \u00e9s efectiu en pacients amb <strong>glucogen hep\u00e0tic esgotat<\/strong>. Per tant, no \u00e9s efectiu en <strong>dej\u00fa prolongat<\/strong>, <strong>insufici\u00e8ncia adrenal<\/strong>, <strong>hipogluc\u00e8mia cr\u00f2nica<\/strong> i <strong>hipogluc\u00e8mia indu\u00efda per alcohol<\/strong>.<\/p>\n\n\n<div class=\"destacat-blog\">\n\n\n<h3 class=\"wp-block-heading\"><strong>Hipogluc\u00e8mia<\/strong><\/h3>\n\n\n\n<p>La <strong>hipogluc\u00e8mia<\/strong> es defineix com <strong>qualsevol episodi<\/strong>, amb s\u00edmptomes o sense, en qu\u00e8 els <strong>nivells plasm\u00e0tics de glucosa<\/strong> se situen per sota de <strong>70 mg\/dL<\/strong> o <strong>3.9 mmol\/L<\/strong>. Es calcula que els <strong>pacients amb DM1<\/strong> poden tenir una <strong>mitjana de dos episodis d\u2019hipogluc\u00e8mia simptom\u00e0tica\/setmana<\/strong> i <strong>un de greu a l\u2019any<\/strong> mentre que els <strong>pacients amb DM2<\/strong> l\u2019<strong>estimaci\u00f3 d\u2019hipogluc\u00e8mia greu <\/strong>\u00e9s de <strong>12 episodis\/100 pacients\/any<\/strong>. <\/p>\n\n\n\n<p>Aquests <strong>episodis<\/strong> poden ser causats per <strong>dosis inadequades d\u2019antidiab\u00e8tics <\/strong>sumades a una <strong>alimentaci\u00f3 insuficient <\/strong>i <strong>falta d\u2019exercici f\u00edsic<\/strong>.<\/p> <\/div>\n\n\n\n<p>A la part final de la seva<strong> intervenci\u00f3<\/strong>, Morales va referir-se als <strong>punts clau<\/strong> de <strong>l&#8217;educaci\u00f3 diabetol\u00f2gica<\/strong>: s\u00edmptomes d&#8217;alerta, causes, autotractament a domicili (i en altres entorns com l&#8217;escolar), prevenci\u00f3 de les hipogluc\u00e8mies, registre de la hipogluc\u00e8mia i causa, i informaci\u00f3 al pacient i familiars centrada en la utilitzaci\u00f3 i conservaci\u00f3 del glucag\u00f3. <\/p>\n\n\n\n<p><\/p>\n\n\n\n<p class=\"has-text-align-right\"><strong>Activitat organitzada conjuntament amb:<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image alignright size-full is-resized\"><a href=\"http:\/\/www.scfarmclin.org\/\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/04\/Societat-Catalana-de-Farmacia-Clinica.png\" alt=\"\" class=\"wp-image-62730\" style=\"width:114px;height:74px\" width=\"114\" height=\"74\"\/><\/a><\/figure>\n\n\n\n<p class=\"has-text-align-right\"><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p class=\"has-text-align-right\"><strong>Amb el patrocini de:<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image alignright size-full is-resized\"><a href=\"https:\/\/www.lilly.com\/\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2022\/04\/Lilly.png\" alt=\"\" class=\"wp-image-62726\" style=\"width:103px;height:61px\" width=\"103\" height=\"61\"\/><\/a><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>El passat 7 d&#8217;abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 &#8220;Hipogluc\u00e8mies greus, qu\u00e8 hi podem fer? Indicacions i tractaments&#8221;. Patrocinada per Lilly i organitzada conjuntament amb la Societat Catalana de Farm\u00e0cia Cl\u00ednica, tenia per objectius que els assistents es posessin al dia pel que [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":67930,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[36,16,653,64,654,18,19,197,53,68,69,25,70,300,655,656,657,262,637,658],"class_list":["post-62655","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-alimentacio","tag-alimentacio-i-nutricio","tag-antidiabetics","tag-atencio-farmaceutica","tag-campanya-atencio-diabetis","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-diabetis","tag-farmaceutics","tag-farmacia","tag-farmacia-comunitaria","tag-farmacies","tag-formacio","tag-formacio-continuada","tag-hipoglucemies","tag-hipoglucemies-greus","tag-nivells-plasmatics","tag-oficines-de-farmacia","tag-programa-de-formacio-continuada","tag-risc-de-patir-diabetis"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Nova formaci\u00f3 sobre les indicacions i els tractaments de les hipogluc\u00e8mies greus al COFB - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El passat 7 d&#039;abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 &quot;Hipogluc\u00e8mies greus, qu\u00e8 hi podem fer? Indicacions i tractaments&quot;.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nova formaci\u00f3 sobre les indicacions i els tractaments de les hipogluc\u00e8mies greus al COFB - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El passat 7 d&#039;abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 &quot;Hipogluc\u00e8mies greus, qu\u00e8 hi podem fer? Indicacions i tractaments&quot;.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-13T08:49:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-21T09:18:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"513\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Nova formaci\u00f3 sobre les indicacions i els tractaments de les hipogluc\u00e8mies greus al COFB\",\"datePublished\":\"2022-04-13T08:49:28+00:00\",\"dateModified\":\"2023-09-21T09:18:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/\"},\"wordCount\":977,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg\",\"keywords\":[\"alimentaci\u00f3\",\"Alimentaci\u00f3 i nutrici\u00f3\",\"antidiab\u00e8tics\",\"Atenci\u00f3 farmac\u00e8utica\",\"campanya atenci\u00f3 diabetis\",\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"diabetis\",\"farmac\u00e8utics\",\"Farm\u00e0cia\",\"farm\u00e0cia comunit\u00e0ria\",\"farm\u00e0cies\",\"Formaci\u00f3\",\"formaci\u00f3 continuada\",\"hipogluc\u00e8mies\",\"hipogluc\u00e8mies greus\",\"nivells plasm\u00e0tics\",\"oficines de farm\u00e0cia\",\"programa de formaci\u00f3 continuada\",\"risc de patir diabetis\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/\",\"name\":\"Nova formaci\u00f3 sobre les indicacions i els tractaments de les hipogluc\u00e8mies greus al COFB - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg\",\"datePublished\":\"2022-04-13T08:49:28+00:00\",\"dateModified\":\"2023-09-21T09:18:03+00:00\",\"description\":\"El passat 7 d'abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 \\\"Hipogluc\u00e8mies greus, qu\u00e8 hi podem fer? Indicacions i tractaments\\\".\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg\",\"width\":1024,\"height\":513},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nova formaci\u00f3 sobre les indicacions i els tractaments de les hipogluc\u00e8mies greus al COFB\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nova formaci\u00f3 sobre les indicacions i els tractaments de les hipogluc\u00e8mies greus al COFB - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El passat 7 d'abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 \"Hipogluc\u00e8mies greus, qu\u00e8 hi podem fer? Indicacions i tractaments\".","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/","og_locale":"ca_ES","og_type":"article","og_title":"Nova formaci\u00f3 sobre les indicacions i els tractaments de les hipogluc\u00e8mies greus al COFB - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El passat 7 d'abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 \"Hipogluc\u00e8mies greus, qu\u00e8 hi podem fer? Indicacions i tractaments\".","og_url":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2022-04-13T08:49:28+00:00","article_modified_time":"2023-09-21T09:18:03+00:00","og_image":[{"width":1024,"height":513,"url":"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg","type":"image\/jpeg"}],"author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"6 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Nova formaci\u00f3 sobre les indicacions i els tractaments de les hipogluc\u00e8mies greus al COFB","datePublished":"2022-04-13T08:49:28+00:00","dateModified":"2023-09-21T09:18:03+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/"},"wordCount":977,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg","keywords":["alimentaci\u00f3","Alimentaci\u00f3 i nutrici\u00f3","antidiab\u00e8tics","Atenci\u00f3 farmac\u00e8utica","campanya atenci\u00f3 diabetis","COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","diabetis","farmac\u00e8utics","Farm\u00e0cia","farm\u00e0cia comunit\u00e0ria","farm\u00e0cies","Formaci\u00f3","formaci\u00f3 continuada","hipogluc\u00e8mies","hipogluc\u00e8mies greus","nivells plasm\u00e0tics","oficines de farm\u00e0cia","programa de formaci\u00f3 continuada","risc de patir diabetis"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/","url":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/","name":"Nova formaci\u00f3 sobre les indicacions i els tractaments de les hipogluc\u00e8mies greus al COFB - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg","datePublished":"2022-04-13T08:49:28+00:00","dateModified":"2023-09-21T09:18:03+00:00","description":"El passat 7 d'abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 \"Hipogluc\u00e8mies greus, qu\u00e8 hi podem fer? Indicacions i tractaments\".","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg","width":1024,"height":513},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2022\/04\/13\/nova-formacio-sobre-les-indicacions-i-els-tractaments-de-les-hipoglucemies-greus-al-cofb\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Nova formaci\u00f3 sobre les indicacions i els tractaments de les hipogluc\u00e8mies greus al COFB"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg",1024,513,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1-150x150.jpg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1-300x150.jpg",300,150,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1-768x385.jpg",768,385,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg",1024,513,false],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg",1024,513,false],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg",1024,513,false],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Hipoglucemies-greus_070422_1_edited-1-1024x513-1.jpg",18,9,false]},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat 7 d&#8217;abril va tenir lloc al Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) la formaci\u00f3 &#8220;Hipogluc\u00e8mies greus, qu\u00e8 hi podem fer? Indicacions i tractaments&#8221;. Patrocinada per Lilly i organitzada conjuntament amb la Societat Catalana de Farm\u00e0cia Cl\u00ednica, tenia per objectius que els assistents es posessin al dia pel que [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/62655","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=62655"}],"version-history":[{"count":2,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/62655\/revisions"}],"predecessor-version":[{"id":68739,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/62655\/revisions\/68739"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media\/67930"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=62655"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=62655"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=62655"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}